361 related articles for article (PubMed ID: 31325847)
1. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
[TBL] [Abstract][Full Text] [Related]
4. Validation of the 2018 FIGO cervical cancer staging system.
Matsuo K; Machida H; Mandelbaum RS; Konishi I; Mikami M
Gynecol Oncol; 2019 Jan; 152(1):87-93. PubMed ID: 30389105
[TBL] [Abstract][Full Text] [Related]
5. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
[TBL] [Abstract][Full Text] [Related]
6. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
8. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
9. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
[TBL] [Abstract][Full Text] [Related]
10. Early cervical adenocarcinoma: selection criteria for radical surgery.
Schorge JO; Lee KR; Lee SJ; Flynn CE; Goodman A; Sheets EE
Obstet Gynecol; 1999 Sep; 94(3):386-90. PubMed ID: 10472864
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.
Kavallaris A; Chalvatzas N; Gkoutzioulis A; Zygouris D
Arch Gynecol Obstet; 2021 Apr; 303(4):1039-1047. PubMed ID: 33068159
[TBL] [Abstract][Full Text] [Related]
12. A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
Kong TW; Piao X; Chang SJ; Paek J; Lee Y; Lee EJ; Ryu HS
Int J Gynecol Cancer; 2016 Jan; 26(1):184-91. PubMed ID: 26512782
[TBL] [Abstract][Full Text] [Related]
13. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
[TBL] [Abstract][Full Text] [Related]
14. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
[TBL] [Abstract][Full Text] [Related]
15. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
Cooke EW; Pappas L; Gaffney DK
Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
[TBL] [Abstract][Full Text] [Related]
16. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
17. Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.
Wu SG; Sun JY; He ZY; Chen QH; Zhou J
J Gynecol Oncol; 2017 Nov; 28(6):e81. PubMed ID: 29027399
[TBL] [Abstract][Full Text] [Related]
18. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
20. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy.
Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM
Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
